Literature DB >> 544114

The prognosis of anterior myocardial infarction revisited: a community-wide study.

H L Kennedy, R J Goldberg, M Szklo, J A Tonascia.   

Abstract

A study was carried out in metropolitan Baltimore in which the short- and long-term prognosis of 655 patients with anterior myocardial infarction (MI) was compared with that of 520 patients with inferior/posterior MI. The study was performed on a community-wide basis in two time periods before the clinical introduction and widespread use of beta-blockade therapy. After simultaneous adjustment for several socio-demographic and clinical variables, the in-hospital case fatality rate was greater for patients with anterior (27.5%) than for those with inferior/posterior MI (22.9%) (p less than 0.05). Similarly, for those discharged alive from the hospital and followed up for as long as 10 years, patients with infarction of the anterior wall had a significantly poorer long-term survival than that of patients with infarction of the inferior/posterior wall (p less than 0.05). These results suggest that closer surveillance should be directed at patients with anterior myocardial infarction, both during the acute phase and after hospital discharge.

Entities:  

Mesh:

Year:  1979        PMID: 544114     DOI: 10.1002/clc.4960020612

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  2 in total

1.  Prehospital 12-Lead Electrocardiogram within 60 Minutes Differentiates Proximal versus Nonproximal Left Anterior Descending Artery Myocardial Infarction.

Authors:  Robert A Aertker; Colin M Barker; H Vernon Anderson; Ali E Denktas; Gregory M Giesler; Vinay R Julapalli; John F Ledoux; David E Persse; Stefano Sdringola; Mary T Vooletich; James J McCarthy; Richard W Smalling
Journal:  West J Emerg Med       Date:  2011-11

2.  Machine Learning to Predict the 1-Year Mortality Rate After Acute Anterior Myocardial Infarction in Chinese Patients.

Authors:  Yi-Ming Li; Li-Cheng Jiang; Jing-Jing He; Kai-Yu Jia; Yong Peng; Mao Chen
Journal:  Ther Clin Risk Manag       Date:  2020-01-09       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.